Corebridge Financial’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Corebridge Financial’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,293	Closed	-$576K	–	3065
2024 Q3	$576K	Sell	17,293 -107	-0.6%	-$3.68K	﹤0.01%	1654
2024 Q2	$470K	Buy	+17,400	New	+$343K	﹤0.01%	1722

Corebridge Financial's LBPH Position: Q4 2024 in Review

Corebridge Financial sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 17,293 shares — an estimated $576K sold.

Corebridge Financial first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $576K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Corebridge Financial reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Corebridge Financial sold 17,293 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $576K.
Corebridge Financial first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Corebridge Financial's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $576K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Corebridge Financial's 13F filing for Q4 2024, filed 11 Feb 2025.